IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a ...

Researchers designed a CRISPR-based test that rapidly detects low levels ... It also detected multi-drug-resistant Staphylococcus aureus DNA without prior amplification at concentrations that ...

Researchers designed a CRISPR-based test that rapidly detects low levels of pathogen genetic material in blood. This is done ...

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target ...

University of Adelaide's Dr Rudrarup Bhattacharjee, Dr Adrienne Sullivan and Professor Jose Polo received funding from the ...

CRISPR MarketThe CRISPR Market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.

highly sensitive detection of multi-drug-resistant bacteria and other pathogens at low concentrations. Researchers designed a CRISPR-based test that rapidly detects low levels of pathogen genetic ...

Researchers designed a CRISPR-based test that rapidly detects low levels ... It also detected multi-drug-resistant Staphylococcus aureus DNA without prior amplification at concentrations that ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy for its second use, approving the drug for transfusion-dependent beta ...

The platform integrates CRISPR-based methodologies, screening capabilities ... "Understanding which targets are truly viable for drug development is a complex challenge," said Sara Tomaselli ...